Compare ADMA Biologics Inc (ADMA) vs SMX Security Matters plc (SMX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs SMX Security Matters plc — how do they compare? ADMA Biologics Inc trades at $9.28 (market cap $2.13B), while SMX Security Matters plc trades at $15.13 (market cap $15.08M). The key difference: ADMA Biologics Inc is far larger — about 141.2× SMX Security Matters plc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| ADMA | SMX | |
|---|---|---|
Market Cap | $2.13B | $15.08M |
Sector | Health | Technology |
52-Week High | $20.38 | $569.32K |
52-Week Low | $7.60 | $12.87 |
Enterprise Value | $2.20B | $12.05M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
SMX (Security Matters PLC) trades at $16.955, up 12.66% today, following two reverse stock splits in May and June 2026. The technical outlook is neutral with mixed moving averages and oscillators, while fundamentals show a P/B of 1.84 but negative ROE and ROA. Recent news highlights the company's focus on recycled plastic traceability and regulatory tailwinds from state recycling mandates.
Outlook is speculative given negative profitability and recent corporate actions. Investment opportunity hinges on adoption of its Circularity-as-a-Service platform, but risks include execution challenges and intense competition in sustainability tech. Wall Street sentiment appears cautious pending evidence of revenue growth and margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
